Zevra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	62.41	33.79	43.05	65.47	112.35
Short-Term Investments	128.61	35.71	24.69	17.38	-
Cash & Short-Term Investments	191.01	69.5	67.74	82.85	112.35
Cash Growth	174.85%	2.60%	-18.24%	-26.26%	2566.65%
Accounts Receivable	23.26	10.51	17.38	8.3	1.53
Inventory	1.74	1.97	-	-	-
Other Current Assets	7	4.05	1.82	1.69	1.18
Total Current Assets	223.01	86.03	86.94	92.83	115.06
Net Property, Plant & Equipment	1.7	1.01	1.53	1.78	2.03
Other Intangible Assets	6.42	68.99	69.23	-	-
Goodwill	4.7	4.7	4.7	-	-
Long-Term Investments	47.88	6.01	-	20	15.42
Other Long-Term Assets	1.02	11.38	9.94	0.72	0.44
Total Assets	284.73	178.13	172.33	115.34	132.94
Accounts Payable	11.6	25.46	28.4	6.17	3.04
Accrued Expenses	13.71	-	-	-	-
Short-Term Debt	-	-	37.7	-	-
Current Portion of Leases	0.42	0.42	0.54	0.48	0.36
Other Current Liabilities	13.55	8.19	7.07	5.37	0.84
Total Current Liabilities	39.28	34.07	73.72	12.02	4.23
Long-Term Debt	61.93	59.5	5.07	12.8	-
Long-Term Leases	0.86	0.37	0.46	0.84	1.23
Other Long-Term Liabilities	28.01	44.52	31.22	14.55	0.36
Total Long-Term Liabilities	90.8	104.4	36.74	28.2	1.59
Total Liabilities	130.07	138.46	110.46	40.22	5.82
Common Stock	0.01	0.01	0	0	0
Treasury Stock	-10.98	-10.98	-10.98	-7.54	-2.81
Additional Paid-in Capital	588.46	555.3	472.66	436.27	396.96
Accumulated Other Comprehensive Income	-0.76	0.63	-	-	-
Retained Earnings	-422.06	-505.29	-399.78	-353.73	-267.03
Shareholders' Equity	154.66	39.67	61.91	75.01	127.12
Total Liabilities & Equity	284.73	178.13	172.33	115.34	132.94
Total Debt	63.21	60.3	43.77	14.12	1.59
Net Cash (Debt)	127.81	9.2	23.97	68.72	110.76
Net Cash Growth	1289.18%	-61.62%	-65.12%	-37.95%	-
Net Cash Per Share	2.23	0.20	0.68	1.99	3.72
Book Value	154.66	39.67	61.91	75.01	127.12
Book Value Per Share	2.70	0.86	1.75	2.17	4.27
Tangible Book Value	143.54	-34.03	-12.02	75.01	127.12
Tangible Book Value Per Share	2.51	-0.74	-0.34	2.17	4.27

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q